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CASE REPORT
First preimplantation genetic testing case for monogenic disease in Latvia
Dmitry Perminova, Ludmila Volozonokaa,b, Liene Korņejevaa, Evija Jokste-Pīmanea, Arita Blumbergaa,
Sandra Krasuckaa, Nellija Seimuskinaa, Irina Kovaļovaa and Violeta Fodinaa
a “IVF Riga” IVF and Reproductive Genetics Clinic, Zaļa iela 1, Riga, Latvija; bRiga Stradins University, Dzirciema iela 16, Riga, Latvija
ABSTRACT
Huntington’s disease (HD) is fatal neurodegenerative disease caused by a (CAG) triplet repeat expansion
in the Huntingtin (HTT) gene. Inheritance pattern of the disease is autosomal dominant and onset
depending on triplet repeat count. Transgenerational HD transmission can be avoided by preimplantation
genetic diagnosis (PGD). Here, we report the first preimplantation genetic testing case for monogenic
disease, in Latvia. The result of our work led to the birth of healthy child with normal HTT alleles in his
genome. We describe a PGD strategy and testing algorithm that can be applied to any couple at risk of
transmitting monogenic disease.
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It is believed that rate of genetic diseases is growing rapidly all
over the world. Nevertheless, it is important to know that the
number of diseases does not increase, but diagnostic capabilities
become much more accessible, as well as new genetic diseases
are better recognized.
Confirmed diagnosis for a particular condition provides fam-
ily an opportunity to choose a specific method of treatment if
available, clarify the prognosis and gives estimations regarding
reoccurrence risk within a family. Until recent in Latvia even if
the parents knew about the increased risk of genetic diseases for
their offspring, it was difficult to avoid or change it. The earliest
time for diagnosing a genetic disorder was during prenatal test-
ing, and if the diagnosis has been confirmed, the family faced a
choice – to terminate the pregnancy or save, knowing that the
baby will not be born healthy. Both of these decisions are com-
plex and emotionally difficult to be accept. Currently a method
that allows carrying out genetic analysis of embryos before their
implantation into the uterine cavity has become available in
Latvia, thus avoiding the risk of certain genetic abnormalities in
the offspring. This method is called preimplantation genetic diag-
nosis (PGD) [1].
Two major testing strategies exist for PGD – direct mutation
detection and indirect testing of mutated allele commonly known
as linkage analysis of single nucleotide polymorphisms (SNPs) or
short tandem repeats (STRs) flanking the mutation region. These
techniques are used after embryonic (preferentially) trophecto-
derm cells biopsy following whole genome amplification (WGA)
[2]. To increase embryo implantation rates after PGD chromo-
some analysis (preimplantation genetic screening – PGS) is rec-
ommended, it provides useful information about chromosomes
of unaffected embryos suitable for transfer. Comparative genomic
hybridization (CGH) is a gold standard tool for PGS [3].
Here, we report our PGD strategy for couple carrying HTT
mutation following birth of a healthy child after PGD/PGS.
Developed algorithm further can be applied to any couple at risk
of transmitting a monogenic disease.
Materials and methods
Family anamnesis
Family with confirmed Huntington’s Chorea mutation willing
to undergo preimplantation genetic testing sought for such pos-
sibility in an ‘IVF Riga’ (Riga, Latvia) IVF and reproductive
genetics clinic in April 2015. They underwent detailed genetic
counseling regarding available options. Informed consent was
obtained.
Clinically healthy woman (29 years old) had 38 ± 2 CAG
repeats in a HTT gene (mild HD, late onset or incomplete pene-
trance), allele inherited from father, who died of Huntington’s
Chorea at the age of 64 and had 40 CAG repeats (adult-onset
HD, symptoms starting at the age of 41).
Controlled ovarian hyperstimulation
Controlled ovarian hyperstimulation was performed in a short
protocol (10 days) with follitropinum alfa (Gonal-F cumulative
dose 2000 IU), GnRH antagonist Ganirelixum (Orgalutran
0.25mg/0.5ml) was added on day seven, and on the day 10,
human choriongonadotropinum Pregnyl 5000 IU was used as an
ovulation trigger.
Preclinical work-up
Before processing this clinical case, preclinical work-up was
done:
 Selection of HTT gene-linked microsatellites – STR
markers (flanking HTT gene 2Mb upstream and down-
stream) was done using UCSC genomic browser.
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 Design of STR-specific and HTT CAG-expansion flanking
primers.
 Optimization of multiplex STR markers seminested PCR.
 Family linkage analysis – STR marker informativeness
evaluation and haplogroup establishment.
 Confirmation of HTT CAG alleles in a family by fluores-
cent PCR (fPCR) followed by fragment size analysis.
IVF and embryo biopsy
Oocytes were fertilized using ICSI method. Fertilized zygotes
were cultivated in Life Global universal medium with 10% pro-
tein supplementation in 6% CO2 and 5% O2 environment condi-
tions in EmryoScope (Vitrolife) incubator that allows
uninterruptable embryo development monitoring using time-
lapse system. On day 4 of development, all normally cleaved
embryos underwent laser-assisted hatching with RI Saturn laser
system to achieve embryo hatching on day 5.
During the punction, 16 oocytes were retrieved, 13 of them
were mature, and three had germinal vesicles. After oocytes fer-
tilization with ICSI method and cultivation process, seven
embryos become blastocysts and underwent TE biopsy.
Performance of HTT PGD clinical case
Lysis and whole-genome amplification (WGA) of embryo TE
biopsies was done using SureMDA kit (Illumina). Embryo hap-
logroup analysis was carried out using multiplex seminested
fPCR for STR-markers and HTT CAG-expansion followed
by amplified product fragment size analysis on capillary
electrophoresis. Embryo chromosome analysis was performed
using 24Sure (Illumina) protocol.
Results
All embryos underwent HTT adjacent STR marker testing and
direct CAG repeat sizing (Figure 1). PGD mother’s (P2–2) HTT
CAG triplet size was shorter for two triplets comparing to her
father’s allele (P1–1), they CAG repeat sizing was performed at
two different laboratories. We included also not fertilized oocyte
with three pronuclei (Figure 1, e9) for testing. It had three alleles
and some marker allele dropout was observed.
Embryos 7 and 12 (Figure 1, e7 and e12) were tested for
chromosome aneuploidies, because they showed better develop-
ment according to EmbryoScope development evaluation.
Embryo 7 showed chromosome 8 mosaic trisomy, and embryo
12 had normal number of chromosomes. These embryos also
were tested for CAG repeat mutation expansion in other labora-
tory, which confirmed our results.
Pedigree includes all family members, informative STR markers
are shown. Embryos obtained from PGD family are numerated
with ‘e’ (e9 is fertilized oocyte, which stopped developing on day
1). The numbers indicate STR-marker amplified product sizes.
Position of genetic markers is aligned sequentially on the chromo-
some without distance precision. Red rectangle indicates mutated
HTT allele. CAG expansion in HTT is given with resolution of ± 2
triplets.
After the PGD and PGS analyses were done, chosen embryo
(e12) thawing and subsequent transfer was performed. Two
weeks later, HCG level in mother’s blood was 1891mU/mL,







































































































































































Figure 1. Pedigree of the PGD family with linkage and embryo images.
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progesterone level 103 nmol/L, later 70 h after that HCG level
was 5297mU/mL, progesterone level – 104 nmol/L.
The pregnancy was uneventful. A healthy child was born on
the week 41. The labor complication was shoulder dystocia.
Baby’s weight was 4400 g, height 57 cm. Apgar score rate was 6
after first minute and 9 after five minutes.
After birth, sample of umbilical cord blood was obtained and
DNA was extracted. CAG expansion was tested and results con-
firmed normal paternal and maternal alleles with CAG expansion
20/25 ± 2 triplets in a child, what fully confirms our methodology
precision.
Conclusions
 For embryo preimplantation genetic testing, we used fol-
lowing algorithm:
 To access loci of interest, we performed adjacent STR
marker haplotype testing and direct mutation testing
(HTT gene CAG sizing).
 To exclude embryo aneuploidies, we performed
aCGH in mutation-free embryos suitable for transfer.
 We confirmed HTT (CAG) allele genotype of born
child in cord blood.
 According to statistics for autosomal dominant type of
inheritance, half of the acquired embryos should be
mutated. Regardless of statistical data, our results show
only 25% mutated embryos. This can be explained by the
small cohort for which the analysis was carried out.
 Our PGD testing algorithm was successful and is further
applicable for other PGD cases with some modifications
depending on inheritance pattern of genetic disorder.
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